These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8939278)

  • 1. Serological alpha 1-antichymotrypsin in patients with probable senile dementia of Alzheimer type: a short-term longitudinal study.
    Licastro F; Davis LJ; Polazzi E; Rossi S; Cucinotta D
    Alzheimer Dis Assoc Disord; 1996; 10(4):192-6. PubMed ID: 8939278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased serum alpha 1-antichymotrypsin in patients with probable Alzheimer's disease: an acute phase reactant without the peripheral acute phase response.
    Licastro F; Morini MC; Polazzi E; Davis LJ
    J Neuroimmunol; 1995 Mar; 57(1-2):71-5. PubMed ID: 7535791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monomeric and polymeric forms of alpha-1 antichymotrypsin in sera from patients with probable late onset Alzheimer's disease.
    Licastro F; Sirri V; Trerè D; Davis LJ
    Dement Geriatr Cogn Disord; 1997; 8(6):337-42. PubMed ID: 9370085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum alpha 1-antichymotrypsin in senile dementia].
    Nagao T; Hamamoto M; Hagiwara M; Kanda A; Ichiseki H; Miyazaki T; Isse K; Tanaka K; Ogura M; Tsushima T
    Nihon Ronen Igakkai Zasshi; 1992 Oct; 29(10):778-82. PubMed ID: 1460783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute phase reactant alpha 1-antichymotrypsin is increased in cerebrospinal fluid and serum of patients with probable Alzheimer disease.
    Licastro F; Parnetti L; Morini MC; Davis LJ; Cucinotta D; Gaiti A; Senin U
    Alzheimer Dis Assoc Disord; 1995; 9(2):112-8. PubMed ID: 7662323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum alpha 1-antichymotrypsin is not a useful marker for Alzheimer's disease or dementia in Parkinson's disease.
    Kuiper MA; van Kamp GJ; Bergmans PL; Scheltens P; Wolters EC
    J Neural Transm Park Dis Dement Sect; 1993; 6(2):145-9. PubMed ID: 8117411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum concentration of alpha 1-antichymotrypsin is elevated in patients with senile dementia of the Alzheimer type.
    Matsubara E; Amari M; Shoji M; Harigaya Y; Yamaguchi H; Okamoto K; Hirai S
    Prog Clin Biol Res; 1989; 317():707-14. PubMed ID: 2690117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood levels of alpha-1-antichymotrypsin and risk factors for Alzheimer's disease: effects of gender and apolipoprotein E genotype.
    Licastro F; Masliah E; Pedrini S; Thal LJ
    Dement Geriatr Cogn Disord; 2000; 11(1):25-8. PubMed ID: 10629358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of elevated alpha 1-antichymotrypsin with cognitive impairment in a prospective study of the very old.
    Gabriel SM; Marin DB; Aisen PS; Lantz M; Altstiel LD; Davis KL; Mohs RC
    Am J Psychiatry; 1998 May; 155(5):698-700. PubMed ID: 9585727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma and cerebrospinal fluid alpha1-antichymotrypsin levels in Alzheimer's disease: correlation with cognitive impairment.
    DeKosky ST; Ikonomovic MD; Wang X; Farlow M; Wisniewski S; Lopez OL; Becker JT; Saxton J; Klunk WE; Sweet R; Kaufer DI; Kamboh MI
    Ann Neurol; 2003 Jan; 53(1):81-90. PubMed ID: 12509851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha 1-antichymotrypsin as a possible biochemical marker for Alzheimer-type dementia.
    Matsubara E; Hirai S; Amari M; Shoji M; Yamaguchi H; Okamoto K; Ishiguro K; Harigaya Y; Wakabayashi K
    Ann Neurol; 1990 Oct; 28(4):561-7. PubMed ID: 2147546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum alpha 1-antichymotrypsin level as a marker for Alzheimer-type dementia.
    Lieberman J; Schleissner L; Tachiki KH; Kling AS
    Neurobiol Aging; 1995; 16(5):747-53. PubMed ID: 8532107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-1-antichymotrypsin and oxidative stress in the peripheral blood from patients with probable Alzheimer disease: a short-term longitudinal study.
    Licastro F; Pedrini S; Davis LJ; Caputo L; Tagliabue J; Savorani G; Cucinotta D; Annoni G
    Alzheimer Dis Assoc Disord; 2001; 15(1):51-5. PubMed ID: 11236825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood-brain barrier permeability of the demented elderly as studied by cerebrospinal fluid-serum albumin ratio.
    Wada H
    Intern Med; 1998 Jun; 37(6):509-13. PubMed ID: 9678683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha 1-antichymotrypsin and IL-1 beta are not increased in CSF or serum in Alzheimer's disease.
    Pirttila T; Mehta PD; Frey H; Wisniewski HM
    Neurobiol Aging; 1994; 15(3):313-7. PubMed ID: 7936055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between serum alpha 1-antichymotrypsin and Alzheimer's disease.
    Hinds TR; Kukull WA; Van Belle G; Schellenberg GD; Villacres EC; Larson EB
    Neurobiol Aging; 1994; 15(1):21-7. PubMed ID: 8159260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Examination of acute phase proteins concentrations in children with allergic rhinitis].
    Steiner I; Sobieska M; Pucher B; Grzegorowski M; Samborski W
    Ann Acad Med Stetin; 2006; 52(2):33-7; discussion 37. PubMed ID: 17633124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated plasma levels of alpha-1-anti-chymotrypsin in age-related cognitive decline and Alzheimer's disease: a potential therapeutic target.
    Porcellini E; Davis EJ; Chiappelli M; Ianni E; Di Stefano G; Forti P; Ravaglia G; Licastro F
    Curr Pharm Des; 2008; 14(26):2659-64. PubMed ID: 18991685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated alpha 1-antichymotrypsin serum levels in a subset of nondemented first-degree relatives of Alzheimer's disease patients.
    Altstiel LD; Lawlor B; Mohs R; Schmeidler J; Dalton A; Mehta P; Davis K
    Dementia; 1995; 6(1):17-20. PubMed ID: 7728215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The significance of measurement of contents of serum serine protease inhibitors in senile dementia of the Alzheimer type].
    Amari M; Matsubara E; Ishiguro K; Shoji M; Hirai S
    Rinsho Shinkeigaku; 1989 Oct; 29(10):1256-60. PubMed ID: 2605832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.